Rare disease kids, biotech CEO parents

Read more about the article Rare disease kids, biotech CEO parents
Terry Pirovolakis, who raised $4.5 million to build a bespoke biotech company to save his son from SPG50. While Terry’s story is a triumph of the human spirit, it exposes a systemic failure: the parental competence lottery. Should a child’s life depend on their parent's ability to moon-light as a venture capitalist and biotech CEO?
Continue ReadingRare disease kids, biotech CEO parents

Should a child’s life depend on their parent's ability to moonlight as a VC and biotech CEO?The science of genetic medicine has officially entered the era of software-based healing. Yet…